Adaptilens
Ophthalmology & Eye Clinics
$24.5Mtotal raised · 3 rounds on record
$17.5Mlatest round · Series A · Apr 2024 · 2 yr ago
2backers · Xontogeny, Pillar VC
50+team · employees, estimated range
Overview
The Adaptilens A-IOL recaptures the eye’s ability to accommodate by responding to its natural signal to focus without spectacle dependence.
Funding and backers
Total raised
$24.5M
3 rounds on record
Latest round
$17.5M
Series A · Apr 2024 · 2 yr ago
Team
51-200
employees, estimated range
Backers
2
Xontogeny, Pillar VC
The money's age
Long since its last round
30 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Apr 29, 2024
Raised a round Series A $17.5M
Mar 28, 2023
Took on debt financing $1.6M · SEC Form D
May 3, 2022
Recognition Adaptilens won a $75,000 Grand Prize award at the Harvard Innovation Lab's President's Innovation Challenge · adaptilens.com
Jun 3, 2020
Recognition Adaptilens selected as a finalist for the 2020 MassChallenge Boston program · adaptilens.com
2019
Founded
Tractionpublic signals, read monthly
Web presence
top 6%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series A | Apr 2024 | $17.5M | — | streetinsider.com |
| Venture round | Apr 2024 | $7M | — | SEC Form D |
| Debt Financing | Mar 2023 | $1.6M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | ADAPTILENS, LLC | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Liane ClamenExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Xontogeny 
Pillar VC Investors in similar startupsfunds that back the companies most like this one
backs Zilia
Similar startupsby what they do, their industry and backers
TLC Laser Eye Centers is a leading laser eye surgery provider, celebrating 30 years of LASIK experience. Book a Free Consultation near you.
VISUS ONE is a new eye clinic offering laser eye surgery and lens implantation with modern technology and experienced ophthalmologists. It…
REALEYES is a German group of ophthalmology practices and eye clinics with more than 40 locations in northern and southern Germany. It…
Zilia's non-invasive assessment of biomarkers in the eye redefines the way we prevent, diagnose, and treat various diseases.
Moyae is a modern ophthalmology EMR designed for eye clinics. Faster workflows, integrated imaging, eRx, and AI-ready architecture.
Active Optics for the Next Generation of Imaging. Active optical correction for wide-FOV, low-distortion, and eye-adaptive AR/VR displays.
People
Liane Clamen
Executive Officer, Director
John Andres
Director
Terry Kim
Director
William Shea
Director
Robert Doris
Director
Jamie Goldstein
Director
C. Gianna Luca
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Adaptilens Featured in C&EN: Celebrating Founder-Led Biotech Innovation
Adaptilens is proud to be featured in C&EN's insightful article by Rowan Walrath, highlighting the impact of founder-led biotech companies. We're honored by the recognition of our Founder and CEO, Dr. Liane Clamen, and grateful for the spotlight on champi
Read more
Report
Adaptilens: $17.5 MIllion Raised For Transforming The Care For Cataract Surgery
Adaptilens, a pre-clinical company dedicated to transforming the standard of care for cataract surgery, announced the closing of a Series A financing round of $17.5 million led by Perceptive Xontogeny Venture Funds (PXV Funds), with additional investments
Read more
Report
Adaptilens Announces $17.5M in Series A Financing
We are thrilled to announce that Adaptilens has secured $17.5 million in Series A financing, led by Xontogeny and Perceptive Xontogeny Venture Fund, with participation from Pillar VC and Accanto Partners. This significant investment will accelerate the de
Read more
Report
Dr. Clamen featured in the When Science Speaks podcast
In the "When Science Speaks" podcast episode titled "Ophthalmology and Entrepreneurship with Liane Clamen, M.D.," Dr. Clamen discusses her journey from practicing ophthalmology to founding Adaptilens, a company developing innovative intraocular lenses aim
Read more
Report
Dr. Clamen featured in the Amazing Execs episode 102 "Developing a Breakthrough New Ophthalmic Medical Device"
In Episode #102 of the Amazing Execs Show, Dr. Liane Clamen, CEO and founder of Adaptilens, discusses her journey in developing an accommodating intraocular lens designed to restore the eye's natural focusing ability for cataract patients. She shares insi
Read more
Report
Adaptilens won a $75,000 Grand Prize award at the Harvard Innovation Lab's President's Innovation Challenge
Adaptilens was awarded $75,000 in the 2022 President's Innovation Challenge for developing an intraocular lens that restores the eye's ability to focus, offering a revolutionary approach to vision correction. Read the article The post Adaptilens won a $75
Read more
Report
Adaptilens chosen to participate in Harvard's highly selective Launch Lab X GEO accelerator
Adaptilens was honored to participate in the prestigious 2021 Launch Lab X GEO program at Harvard Innovation Labs. This six-month virtual accelerator provided unparalleled access to world-class experts, founder talks, leadership circles, and pitch session
Read more
Report
Dr. Clamen receives the 2021 Massachusetts Next Generation award
In June 2021, the Massachusetts Life Sciences Center (MLSC) announced the 2021 awardees of the Massachusetts Next Generation Initiative (MassNextGen), a program supporting women entrepreneurs in early-stage life sciences companies. Among the five selected
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Chestnut Hill
United States
HQ
50-200 est. staff